Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising adoption of alternative testing procedures to animal testing
3.2.1.2 Increasing prevalence of skin disorders
3.2.1.3 Growing focus on precision cosmetic products
3.2.1.4 Growing investments in the development of advanced in-vitro models
3.2.2 Industry pitfalls & challenges
3.2.2.1 Concerns related to reproducibility across different batches
3.2.2.2 Presence of stringent regulatory approval process
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Reconstructed human epidermis
5.3 Reconstructed human skin
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Skin irritation test
6.3 Skin corrosion test
6.4 Skin sensitization test
6.5 Skin biopsy
6.6 Radioallergosorbent test
6.7 Skin pigmentation test
6.8 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Cosmetics and cosmeceutical companies
7.3 Chemical companies
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 AIVITA Biomedical, Inc.
9.2 BICO - THE BIO CONVERGENCE COMPANY
9.3 CELLnTEC
9.4 EPISKIN
9.5 Henkel AG & Co. KGaA
9.6 Japan Tissue Engineering Co., Ltd.
9.7 Mallinckrodt plc
9.8 STRATICELL
9.9 WEPREDIC Group (Biopredic International)
9.10 ZenBio, Inc.
